Sofos Investments, Inc.

SEC CIK: 0001741736
Latest filing: May 8, 2026

SEC filings (opens in a new tab)

VNDA holding history

Vanda Pharmaceuticals Inc. in every 13F filed by Sofos Investments, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VNDA overview All 13F holders of VNDA Full Q1 2026 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2021

Holdings of VNDA by Sofos Investments, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−185−100.0%	Sold out	Holders
Q3 2021	185	–	–	+10+5.7%	Added	Holders
Q2 2021	175	–	–	+7+4.2%	Added	Holders
Q1 2021	168	$2.52K	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.